Results

Total Results: 818 records

Showing results for "venous thromboembolism".
Users also searched for: vte

561. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-TsBkyewVoFpC7htRmzWJa
     September 03, 2019 - Project; PE, pulmonary embolism; RR, risk ratio; RUTH, Raloxifene Use for the Heart; SE, standard error; VTE … , venous thromboembolism. a Numbers of events reduced for benefits or increased for harms vs comparator

562. Unstoppable: this doctor has been investigated at every level of government. How is he still practicing? | PSNet
     psnet.ahrq.gov/issue/unstoppable-doctor-has-been-investigated-every-level-government-how-he-still-practicing
     September 16, 2020 - Newspaper/Magazine Article Unstoppable: this doctor has been investigated at every level of government. How is he still practicing? Citation Text: Unstoppable: this doctor has been investigated at every level of government. How is he still practicing? Waldman A. ProPublica. August…

563. AHRQ-Funded Patient Safety Project Highlights (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/highlights/ps-project-highlights-harms.pdf
     August 01, 2025 - thromboembolism (VTE). … venous thromboembolism (HA VTE) via effective implementation of a venous thromboembolism (VTE) prevention … the 2008 AHRQ Hospital-Associated Venous Thromboembolism (VTE) Prevention Guide in a leading effort … thromboembolism (VTE) outcomes. … thromboembolism (VTE), through use of an evidence-based and system-supported interactive VTE Safety

564. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/837963/psn-pdf
     August 31, 2022 - Delayed Diagnosis of Mesenteric Ischemia August 31, 2022 Robles A, Utter GH. Delayed Diagnosis of Mesenteric Ischemia. PSNet [internet]. 2022. https://psnet.ahrq.gov/web-mm/delayed-diagnosis-mesenteric-ischemia Disclosure of Relevant Financial Relationships: As a provider accredited by the Accreditation Council for…

565. July Syndrome | PSNet
     psnet.ahrq.gov/web-mm/july-syndrome
     July 01, 2011 - The patient's nurse noticed that there were no orders for venous thromboembolism (VTE) prophylaxis, despite … the patient being at high risk for VTE. … The intern assumed that VTE prophylaxis was contraindicated, since the fellow had not ordered VTE prophylaxis … Therefore, the patient was not prescribed VTE prophylaxis. … on the ICU team was reviewing orders for the patient and realized that the patient was not receiving VTE

566. Understanding national coverage policies. Navigating the maze of HACs, serious reportable events, and wrong surgical sites. | PSNet
     psnet.ahrq.gov/issue/understanding-national-coverage-policies-navigating-maze-hacs-serious-reportable-events-and
     June 28, 2017 - Commentary Understanding national coverage policies. Navigating the maze of HACs, serious reportable events, and wrong surgical sites. Citation Text: Cook J, D'Amato C, Garrett G, et al. Understanding national coverage policies. Navigating the maze of HACs, serious reportable events, a…

567. Additional References for PMCoE Perinatal CHIPRA Project (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/chipra-mc4-addtl-refs.pdf
     August 14, 2012 - Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest … Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest

568. American College of Obstetricians and Gynecologists (ACOG) (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085additionalreferences.pdf
     August 14, 2012 - Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest … Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest

569. American College of Obstetricians and Gynecologists (ACOG) (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0082additional.pdf
     August 14, 2012 - Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest … Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest

570. American College of Obstetricians and Gynecologists (ACOG) (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085addresource.pdf
     August 14, 2012 - Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest … Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest

571. American College of Obstetricians and Gynecologists (ACOG) (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0084additional.pdf
     August 14, 2012 - Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest … Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest

572. Zvvry6Wa4Sgj-Ejb3Brcvy (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
     November 01, 2013 - Effects In general, women receiving medications for breast cancer risk reduction are less likely to have VTE … Women with a personal or family history of venous thromboembolism are at higher risk for these ad- verse

573. Triggers and Trigger Tools | PSNet
     psnet.ahrq.gov/primer/triggers-and-trigger-tools
     September 15, 2024 - February 15, 2023 Modes of failure in venous thromboembolism prophylaxis.

574. Archived: Evidence Summary: Aspirin Use to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     April 11, 2016 - Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med . 2012;367:1979-87. … Thromboembolism; bid = twice daily; BMD = British Male Doctors; CDPA = Coronary Drug Project Aspirin … Thromboembolism; BMD = British Male Doctors; CDPA = Coronary Drug Project Aspirin; CVD = cardiovascular … Thromboembolism; BMD = British Male Doctors; CDPA = Coronary Drug Project Aspirin; CDPRG = Coronary … Thromboembolism; BMD = British Male Doctors; CVD = cardiovascular disease; DVT = deep venous thrombosis

575. Making Health Care Safer II, Executive Summary (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/evidence-based-reports/services/quality/patientsftyupdate/ptsafetysum.pdf
     March 01, 2013 - problems that occur approximately once per 100 hospitalizations as “common;” examples include falls, venous … thromboembolism (VTE), potential adverse drug events, or pressure ulcers. … Examples include most fall prevention programs, VTE prophylaxis, and medical history abbreviations … Moderate (pneumonia) Moderate Little/Not difficult Strategies to increase appropriate prophylaxis for venous … thromboembolism; brief review Common/ Moderate High Moderate (bleeding) Low Little/Moderate Preventing

576. AHRQ Safety Program for MRSA Prevention
     www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa/169-cusp-science-safety-slides.pptx
     October 01, 2024 - Surgeon asks Susan if she has family history of venous thromboembolism (VTE). … The hospital does not have a standard VTE risk assessment protocol. … Unaware of what VTE is, Susan answers that she has no family history of VTE.

577. Refining Key Questions: Interactive Case Study Quiz
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
     May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…

578. Refining Key Questions: Interactive Case Study Quiz
     effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
     May 01, 2010 - Refining Key Questions: Interactive Case Study Quiz Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs. Usual Care in the Hospital Setting Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Uses vs.…

579. Fundamentals of Medicare Patient Safety Surveillance: Intent, Relevance, and Transparency (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Hunt.pdf
     July 01, 2004 - Fundamentals of Medicare Patient Safety Surveillance: Intent, Relevance, and Transparency 105 Fundamentals of Medicare Patient Safety Surveillance: Intent, Relevance, and Transparency David R. Hunt, Nancy Verzier, Susan L. Abend, Courtney Lyder, Lisa J. Jaser, Nancy Safer, Paul Davern Abstract The Medicar…

580. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
     May 06, 2002 - The relative risk increase in venous thromboembolism from tamoxifen or raloxifene does not appear to … Risk of venous thromboembolism in users of hormone replacement therapy.